Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR)

Med Sci Monit. 2008 Feb;14(2):CR57-61.

Abstract

Background: The monoamine oxidase-A (MAOA) gene plays a vital role in the metabolism of neurotransmitters, e.g, serotonin, norepinephrine, and dopamine. A polymorphism in the promoter region (MAOA-uVNTR) affects transcriptional efficiency. Allelic variation in MAOA-uVNTR has been associated with body mass index (BMI). We extended previous work by examining relations among this polymorphism and serum lipid levels.

Material/methods: The sample consisted of 74 males enrolled in a study of caregivers for relatives with dementia. Regression models, adjusted for age, race, group status (caregiver/control), and cholesterol lowering medication (yes/no), were used to examine associations between high verses low MAOA-uVNTR activity alleles and total cholesterol, HDL, LDL, VLDL, LDL/HDL ratio, triglycerides, and BMI.

Results: Higher total cholesterol (p<0.03), LDL/HDL ratio (p<0.01), triglycerides (p<0.02), and VLDL (p<0.02) were associated with low activity MAOA-uVNTR alleles. HDL and LDL were modestly related to MAOA-uVNTR activity, however, they did not reach the conventional significance level (p<0.07 and p<0.10, respectively). BMI (p<0.74) was unrelated to MAOA-uVNTR transcription.

Conclusions: The present findings suggest that MAOA-uVNTR may influence lipid levels and individuals with less active alleles are at increased health risk.

Publication types

  • Editorial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Base Sequence
  • Body Mass Index
  • Coronary Disease / etiology
  • Coronary Disease / genetics
  • DNA Primers / genetics
  • Humans
  • Lipids / blood*
  • Male
  • Middle Aged
  • Minisatellite Repeats*
  • Monoamine Oxidase / genetics*
  • Polymorphism, Genetic
  • Promoter Regions, Genetic*
  • Risk Factors

Substances

  • DNA Primers
  • Lipids
  • Monoamine Oxidase